emjreviews.com14h
Limited Value of Routine Follow-Up in Lymphoma Remission
Research shows routine follow-up misses most relapses in lymphoma patients in remission, highlighting the need for improved ...
King Faisal Prize Laureates in Medicine & Science Receive $400,000 For their Breakthrough Discoveries in Cellular Engineering and Nanotechnology
Professor Michel Sadelain, of Canadian origins, was announced the 2025 laureate for King Faisal Prize in Medicine for his groundbreaking contributions to Chimeric Antigen Receptor (CAR) T-cell therapy ...
ENDPOINTS NEWS11h
Astel­las stops de­vel­op­ing au­tol­o­gous cell ther­a­py us­ing tech from Xyphos buy­out
Astellas has ended work on a cell therapy that it was exploring for CD20-positive B cell lymphomas, the Japan-based pharma ...
Monthly Prescribing Reference12h
2024 Novel Drug and Biological Product Approvals
The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.